Restructuring Activities

9 Months Ended

Sep. 30, 2012

Restructuring and Related Activities [Abstract]

The Company recorded $359 and $390 for the three and nine months ended September 30, 2012, respectively, in restructuring costs for employee separation benefits primarily related to the integration of SeQual Technologies Inc. These charges were recorded in cost of sales ($318 and $349 for the three and nine months ended September 30, 2012, respectively) and selling, general and administrative expenses ($41 for both the three and nine months ended September 30, 2012).

The Company recorded $696 and $2,905 for the three and nine months ended September 30, 2011, respectively, in restructuring costs related to the closure of the Plainfield, Indiana BioMedical manufacturing facility. The Company also recorded $372 and $1,353 for the three and nine months ended September 30, 2011, respectively, for employee separation benefits related to the integration of SeQual Technologies, Inc. An additional $733 was recorded for the nine months ended September 30, 2011 related to various restructuring efforts across the Company. These charges were recorded in cost of sales ($696 and $1,661 for the three and nine months ended September 30, 2011, respectively) and selling, general and administrative expenses ($372 and $2,114 for the three and nine months ended September 30, 2011, respectively), and a $1,216 loss on disposal of assets for the nine months ended September 30, 2011.

The restructuring liability is recorded in other current liabilities on the condensed consolidated balance sheets. The following tables summarize the Company’s restructuring activities for the three and nine months ended September 30, 2012 and 2011:



	Three Months Ended September 30, 2012
	Energy & Chemicals		Distribution & Storage			BioMedical			Corporate		Total
Balance as of July 1, 2012	$	—	$	6		$	225		$	—	$	231
Restructuring charges	—		—			359			—		359
Cash payments and other	—		(4		)	(329		)	—		(333		)
Balance as of September 30, 2012	$	—	$	2		$	255		$	—	$	257



	Nine Months Ended September 30, 2012
	Energy & Chemicals		Distribution & Storage			BioMedical			Corporate		Total
Balance as of January 1, 2012	$	—	$	115		$	998		$	—	$	1,113
Restructuring charges	—		—			390			—		390
Cash payments and other	—		(113		)	(1,133		)	—		(1,246		)
Balance as of September 30, 2012	$	—	$	2		$	255		$	—	$	257



	Three Months Ended September 30, 2011
	Energy & Chemicals		Distribution & Storage			BioMedical			Corporate		Total
Balance as of July 1, 2011	$	—	$	157		$	1,966		$	—	$	2,123
Restructuring charges	—		—			1,068			—		1,068
Cash payments and other	—		(43		)	(1,352		)	—		(1,395		)
Balance as of September 30, 2011	$	—	$	114		$	1,682		$	—	$	1,796



	Nine Months Ended September 30, 2011
	Energy & Chemicals			Distribution & Storage			BioMedical			Corporate			Total
Balance as of January 1, 2011	$	103		$	388		$	2,088		$	—		$	2,579
Restructuring charges	—			26			4,528			437			4,991
Loss on disposal of assets	—			—			(1,216		)	—			(1,216		)
Cash payments and other	(103		)	(300		)	(3,718		)	(437		)	(4,558		)
Balance as of September 30, 2011	$	—		$	114		$	1,682		$	—		$	1,796

- Definition

The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.

+ References+ Details